Related by context. Frequent words. (Click for all words.) 79 MKC# 74 Tesetaxel 73 Initiates Phase II 73 Cetrorelix 73 Meets Primary Endpoint 71 liposomal formulation 71 Sapacitabine 71 Patient Enrollment 71 Daclizumab 71 Panzem R 71 Receives Orphan Drug Designation 71 Completes Enrollment 71 Pivotal Phase III 71 phase IIb clinical 71 Factor VIIa 70 Dapagliflozin 70 Phase III Clinical Trial 70 cardio renal 70 Commences Phase 70 Aliskiren 70 Ambrisentan 70 fibrosis IPF 69 Irinotecan 69 multi kinase inhibitor 69 Epratuzumab 69 Mipomersen 69 includes investigational compounds 69 Onalta 69 Drug Candidate 69 proteasome inhibitor 69 Golimumab 69 Pirfenidone 69 Eculizumab 69 Belimumab 69 Small Molecule 69 FDA Accepts 69 AEG# 69 Initiate Phase 69 histone deacetylase HDAC inhibitor 68 inhaled formulation 68 Voreloxin 68 Lubiprostone 68 phenylalanine ammonia lyase 68 Microplasmin 68 HCV protease inhibitor 68 Pivotal Phase 68 Palifosfamide 68 Nanobody 68 Pivotal Trial 68 pulmonology portfolio 68 Carfilzomib 67 Ustekinumab 67 Pivotal Study 67 Dasatinib 67 R sorafenib tablets 67 Phase Ib II 67 Presents Positive 67 JAK inhibitor 67 Inhalation Aerosol 67 IMC #B 67 HepeX B 67 NEBIDO R 67 Thiarabine 67 cutaneous T 67 refractory chronic lymphocytic 67 humanized anti 67 ALN TTR 67 PRT# 67 Azedra 67 VALSTAR 67 Zolinza 67 investigational compounds 67 CCX# 67 Potassium Chloride Sodium Ascorbate 67 6R BH4 67 Denufosol 67 ATL# [001] 67 TLR9 agonist 67 Ofatumumab 67 Idera Pharmaceuticals 67 vascular disrupting agent 67 TELINTRA 66 Recombinant Human 66 INCB# [001] 66 non alcoholic steatohepatitis 66 Alfimeprase 66 Study Evaluating 66 PSN# [002] 66 castrate resistant prostate cancer 66 CDP# 66 hepatology portfolio 66 JAK1 66 Elesclomol 66 thymalfasin 66 PEG SN# 66 BAY #-# 66 Guanilib 66 Single Dose 66 sunitinib malate 66 Traficet EN 66 Alinia